Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy

PURPOSE: Pregnant and postpartum women are at increased risk of developing severe COVID-19. Monoclonal antibodies (mAbs) are now widely used in high-income countries to treat mild to moderate COVID-19 outpatients at risk for developing severe disease. Very few data are available on the use of mAbs i...

Descripción completa

Detalles Bibliográficos
Autores principales: Manciulli, Tommaso, Modi, Giulia, Campolmi, Irene, Borchi, Beatrice, Trotta, Michele, Spinicci, Michele, Lagi, Filippo, Bartoloni, Alessandro, Zammarchi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900641/
https://www.ncbi.nlm.nih.gov/pubmed/35257291
http://dx.doi.org/10.1007/s15010-022-01777-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900641/
https://www.ncbi.nlm.nih.gov/pubmed/35257291
http://dx.doi.org/10.1007/s15010-022-01777-z

Ejemplares similares